Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2005 Feb;81(1):53–58. doi: 10.1136/sti.2004.009423

Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling

C Bradshaw 1, L Pierce 1, S Tabrizi 1, C Fairley 1, S Garland 1
PMCID: PMC1763716  PMID: 15681724

Abstract

Background: Injecting drug users (IDUs) are a marginalised population, who infrequently access health services for screening for sexually transmitted infections (STIs) and blood borne viruses (BBVs), and are at high risk of these infections.

Objectives: To use street outreach and self collection of samples for STI screening, to establish the prevalence of BBVs and STIs, and to identify risk behaviours among a group of culturally diverse street based IDUs.

Methods: This was a cross sectional study of 314 IDUs in the central business district of Melbourne, Australia, conducted over 3 years (1999–2002). We used street outreach as the recruitment strategy with staff "on foot" in injecting and dealing locations, as well as self collected genital sampling to increase acceptance of screening for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis by polymerase chain reaction (PCR). Individuals were screened for hepatitis A, B, and C, syphilis and HIV, and given the option of a self collected or clinician collected blood sample to increase acceptance of screening for BBVs.

Results: Street outreach was highly effective and self directed STI sampling was more acceptable than practitioner directed sampling (76% versus 9% acceptance, p<0.001). There was a high prevalence of hepatitis C (74%, 95% CI 69 to 79), STIs (8% (5 to 13)), and chlamydia (6% (3 to 10)), and past exposure to hepatitis A and B was common. High rates of recent sharing of injecting equipment, unprotected sex and casual sexual partners, together with low levels of awareness of current hepatitis C infection were identified.

Conclusion: Street outreach and self collected genital samples facilitate screening for STIs and BBVs in IDUs and revealed a high prevalence of infections and risk behaviours.

Full Text

The Full Text of this article is available as a PDF (94.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crofts N., Aitken C. K. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust. 1997 Jul 7;167(1):17–20. doi: 10.5694/j.1326-5377.1997.tb138757.x. [DOI] [PubMed] [Google Scholar]
  2. Crofts N., Cooper G., Stewart T., Kiely P., Coghlan P., Hearne P., Hocking J. Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria. J Viral Hepat. 1997 Sep;4(5):333–338. doi: 10.1046/j.1365-2893.1997.00059.x. [DOI] [PubMed] [Google Scholar]
  3. Crofts N., Hopper J. L., Bowden D. S., Breschkin A. M., Milner R., Locarnini S. A. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust. 1993 Aug 16;159(4):237–241. doi: 10.5694/j.1326-5377.1993.tb137822.x. [DOI] [PubMed] [Google Scholar]
  4. Des Jarlais Don C., Diaz Theresa, Perlis Theresa, Vlahov David, Maslow Carey, Latka Mary, Rockwell Russell, Edwards Vincent, Friedman Samuel R., Monterroso Edgar. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003 Mar 1;157(5):467–471. doi: 10.1093/aje/kwf222. [DOI] [PubMed] [Google Scholar]
  5. François Guido, Hallauer Johannes, Van Damme Pierre. Hepatitis B vaccination: how to reach risk groups. Vaccine. 2002 Nov 22;21(1-2):1–4. doi: 10.1016/s0264-410x(02)00440-1. [DOI] [PubMed] [Google Scholar]
  6. Freeman A. J., Zekry A., Whybin L. R., Harvey C. E., van Beek I. A., de Kantzow S. L., Rawlinson W. D., Boughton C. R., Robertson P. W., Marinos G. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Med J Aust. 2000 Jun 19;172(12):588–591. doi: 10.5694/j.1326-5377.2000.tb124124.x. [DOI] [PubMed] [Google Scholar]
  7. Hocking Jane S., Higgs Peter G., Keenan Cathy M., Crofts Nick. HIV among injecting drug users of Indo-Chinese ethnicity in Victoria. Med J Aust. 2002 Feb 18;176(4):191–192. doi: 10.5694/j.1326-5377.2002.tb04361.x. [DOI] [PubMed] [Google Scholar]
  8. Knox Janet, Tabrizi Sepehr N., Miller Penny, Petoumenos Kathy, Law Mathew, Chen Shujun, Garland Suzanne M. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis. 2002 Nov;29(11):647–654. doi: 10.1097/00007435-200211000-00006. [DOI] [PubMed] [Google Scholar]
  9. Law Matthew G., Batey Robert G. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust. 2003 Mar 3;178(5):197–198. [PubMed] [Google Scholar]
  10. MacDonald M. A., Wodak A. D., Dolan K. A., van Beek I., Cunningham P. H., Kaldor J. M. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust. 2000 Jan 17;172(2):57–61. doi: 10.5694/j.1326-5377.2000.tb139199.x. [DOI] [PubMed] [Google Scholar]
  11. Maher L., Sargent P., Higgs P., Crofts N., Kelsall J., Le T. T. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne. Aust N Z J Public Health. 2001;25(1):50–54. doi: 10.1111/j.1467-842x.2001.tb00550.x. [DOI] [PubMed] [Google Scholar]
  12. Miller Cari L., Tyndall Mark, Spittal Patricia, Li Kathy, Palepu Anita, Schechter Martin T. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002 Jun;79(2):257–265. doi: 10.1093/jurban/79.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miller Maureen, Mella Inge, Moi Harald, Eskild Anne. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):373–379. doi: 10.1097/00126334-200307010-00012. [DOI] [PubMed] [Google Scholar]
  14. Paterson B. A., Tabrizi S. N., Garland S. M., Fairley C. K., Bowden F. J. The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Sex Transm Infect. 1998 Apr;74(2):136–139. doi: 10.1136/sti.74.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Poulin C., Alary M., Bernier F., Carbonneau D., Boily M. C., Joly J. R. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among at-risk women, young sex workers, and street youth attending community organizations in Quebec City, Canada. Sex Transm Dis. 2001 Aug;28(8):437–443. doi: 10.1097/00007435-200108000-00002. [DOI] [PubMed] [Google Scholar]
  16. Reid G., Crofts N., Beyer L. Drug treatment services for ethnic communities in Victoria, Australia: an examination of cultural and institutional barriers. Ethn Health. 2001 Feb;6(1):13–26. doi: 10.1080/13557850124373. [DOI] [PubMed] [Google Scholar]
  17. Resnick R. M., Cornelissen M. T., Wright D. K., Eichinger G. H., Fox H. S., ter Schegget J., Manos M. M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990 Sep 19;82(18):1477–1484. doi: 10.1093/jnci/82.18.1477. [DOI] [PubMed] [Google Scholar]
  18. Rhodes Tim, Lowndes Catherine, Judd Ali, Mikhailova Larissa A., Sarang Anya, Rylkov Andrey, Tichonov Mikhail, Lewis Kim, Ulyanova Nina, Alpatova Tatiana. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS. 2002 Sep 6;16(13):F25–F31. doi: 10.1097/00002030-200209060-00002. [DOI] [PubMed] [Google Scholar]
  19. Rosenthal D. A., Fairley C. K., Garland S. M., Tabrizi S. N., Raynor K., Edwards C., Gregson S., Walsh J. Homeless young people: an important risk group for sexually transmitted infections. Med J Aust. 2000 Mar 6;172(5):244–244. doi: 10.5694/j.1326-5377.2000.tb123928.x. [DOI] [PubMed] [Google Scholar]
  20. Ross M. W., Gold J., Wodak A., Miller M. E. Sexually transmissible diseases in injecting drug users. Genitourin Med. 1991 Feb;67(1):32–36. doi: 10.1136/sti.67.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ross Michael W., Hwang Lu-Yu, Zack Carolyn, Bull Lara, Williams Mark L. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS. 2002 Nov;13(11):769–774. doi: 10.1258/095646202320753736. [DOI] [PubMed] [Google Scholar]
  22. Shafer Kimberly Page, Hahn Judith A., Lum Paula J., Ochoa Kristen, Graves Alison, Moss Andrew. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr. 2002 Dec 1;31(4):422–431. doi: 10.1097/00126334-200212010-00009. [DOI] [PubMed] [Google Scholar]
  23. Tabrizi S. N., Chen S., Borg A. J., Lees M. I., Fairley C. K., Jackson H. D., Gust C. H., Migliorini G., Garland S. M. Patient-administered tampon-collected genital cells in the assessment of Chlamydia trachomatis infection using polymerase chain reaction. Sex Transm Dis. 1996 Nov-Dec;23(6):494–497. doi: 10.1097/00007435-199611000-00010. [DOI] [PubMed] [Google Scholar]
  24. Tabrizi S. N., Chen S., Cohenford M. A., Lentrichia B. B., Coffman E., Shultz T., Tapsall J. W., Garland S. M. Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex Transm Infect. 2004 Feb;80(1):68–71. doi: 10.1136/sti.2003.006239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tabrizi S. N., Paterson B. A., Fairley C. K., Bowden F. J., Garland S. M. Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women. Int J STD AIDS. 1998 Jun;9(6):347–349. doi: 10.1258/0956462981922386. [DOI] [PubMed] [Google Scholar]
  26. Tabrizi S. N., Paterson B., Fairley C. K., Bowden F. J., Garland S. M. A self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis. 1997 Jul;176(1):289–292. doi: 10.1086/517269. [DOI] [PubMed] [Google Scholar]
  27. Williams H., Tabrizi S. N., Lee W., Kovacs G. T., Garland S. Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect. 2003 Feb;79(1):31–34. doi: 10.1136/sti.79.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. van Beek I., Buckley R., Stewart M., MacDonald M., Kaldor J. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med. 1994 Oct;70(5):321–324. doi: 10.1136/sti.70.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Beek I., Dwyer R., Dore G. J., Luo K., Kaldor J. M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998 Aug 15;317(7156):433–437. doi: 10.1136/bmj.317.7156.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van den Hoek A. STD control in drug users and street youth. Genitourin Med. 1997 Aug;73(4):240–244. doi: 10.1136/sti.73.4.240. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES